Skip to main content

Dr. Traer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Traer's full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Internal Medicine, 2006 - 2009
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2006
  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2009 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
    Elie Traer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations